FFG
ALXN

Fortem Financial Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Fortem Financial Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,530
Closed -$387K – 178
2021
Q1 		$387K Sell
2,530
-82
-3% -$12.7K 0.22% 120
2020
Q4 		$408K Sell
2,612
-100
-4% -$12.8K 0.24% 103
2020
Q3 		$310K Sell
2,712
-8,393
-76% -$905K 0.22% 113
2020
Q2 		$1.25M Buy
11,105
+342
+3% +$36.3K 0.96% 34
2020
Q1 		$966K Sell
10,763
-2,656
-20% -$261K 0.88% 41
2019
Q4 		$1.45M Sell
13,419
-3
-0% -$321 1.08% 38
2019
Q3 		$1.31M Buy
+13,422
New +$1.51M 1.12% 41

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Fortem Financial Group's ALXN Position: Q2 2021 in Review

Fortem Financial Group sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 2,530 shares — an estimated $387K sold.

Fortem Financial Group first reported a position in ALXN in Q3 2019 and held it in 7 quarters. The position peaked at $1.45M in Q4 2019. 707 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Fortem Financial Group reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Fortem Financial Group sold 2,530 Alexion Pharmaceuticals shares in Q2 2021, an estimated $387K.
  • Fortem Financial Group first reported a position in Alexion Pharmaceuticals in Q3 2019 and held it in 7 quarters.
  • Fortem Financial Group's Alexion Pharmaceuticals position peaked at $1.45M in Q4 2019.
  • 707 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Fortem Financial Group's 13F filing for Q2 2021, filed 14 Jul 2021.